BlackRock Inc. acquired a new stake in Heartflow, Inc. (NASDAQ: HTFL) in the undefined quarter, acco

FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonst

SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the lea

The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100. The tr

HeartFlow delivered a convincing Q2 with 48% sales growth and gross margins rising to 83%, driving s

Heartflow's AI-powered platform could save countless lives. The company is growing at an impressive

HeartFlow Inc. (NASDAQ:HTFL) shares are trading sharply higher Friday afternoon after the company re

HeartFlow shares are surging Friday after it reported better-than-expected Q2 adjusted EPS results a

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raise

Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and rai

Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular

Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises

JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises th

Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raise

U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected ea

Stifel analyst Rick Wise maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target

Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market

Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results

HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript

Heartflow NASDAQ: HTFL reported second-quarter revenue of $64.1 million, up 48% from a year earlier,

HeartFlow (HTFL) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estima

HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thu

Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session

HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.07) per share which beat the analyst consen

HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $246.0

SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the lea

Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, init

After a week of wild swings that rattled portfolios and left investors guessing, Wall Street analyst

Baird analyst David Rescott initiates coverage on HeartFlow (NASDAQ:HTFL) with a Outperform ratin

The medical technology company reported a notable insider sale in recent filings.

I recommend a buy rating for HeartFlow, Inc. due to its strong clinical workflow integration and exp

Heartflow Plaque Staging TM , the only staging tool based on total plaque volume * , is now included

Heartflow uses artificial intelligence to transform coronary imaging into actionable diagnostic data

Heartflow leverages AI-enabled software to dominate the non-invasive coronary diagnostic market, bac

Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HeartFlow (NASDAQ:HTFL) wit

AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue

In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing

HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and lower

Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raise

HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $228.0

HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.16) per share which beat the analyst consen

Options markets are pricing post-earnings moves between 17.74% and 42.50% on ten small/mid caps repo

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease

JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and lowers th

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raise

U.S. stocks drop, with Dow Jones down 150 points. Signet Jewelers stock rose 11.8% after beating ear

Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and lower